Oppenheimer & Co’s CytRx Corp CYTR Stock Holding History

Oppenheimer & Co’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,417	Closed	-$34K	–	1457
2015 Q3	$34K	Buy	+2,417	New	+$40.9K	﹤0.01%	1318

Other funds holding CYTR

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Oppenheimer & Co's CYTR Position: Q4 2015 in Review

Oppenheimer & Co sold out of CytRx Corp (CYTR) in Q4 2015, closing a stake of 2,417 shares — an estimated $34K sold.

Oppenheimer & Co first reported a position in CYTR in Q3 2015 and held it in 1 quarter. The position peaked at $34K in Q3 2015. 65 funds tracked by Wall St. Rank hold CYTR as of Q4 2015.

Oppenheimer & Co reported no remaining CytRx Corp position as of Q4 2015 after selling out during the quarter.
Oppenheimer & Co sold 2,417 CytRx Corp shares in Q4 2015, an estimated $34K.
Oppenheimer & Co first reported a position in CytRx Corp in Q3 2015 and held it in 1 quarter.
Oppenheimer & Co's CytRx Corp position peaked at $34K in Q3 2015.
65 funds tracked by Wall St. Rank held CytRx Corp as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.